摘要
AIM: To describe distribution of the phosphorothioated antisense oligodeoxynucleotides (PS-asODNs) conjugated to galactosylated poly-L-lysine (Gal-PLL) in mice, and to observe their effects on expression of HBV gene in the 2.2.15 cells and transgenic mice.METHODS: According to the result of direct sequencing of PCR amplified products, a 16 mer phosphorothioate analogue of the antisense oligodeoxynucleotides (PS-asODNs) directed against the HBV U5-like region was conjugated to the hepatotropic Gal-PLL molecules. Its distribution was demonstrated using asODNs labeled with ^32p at the 5' terminus with a T4-polynucleotide Kinase. Its inhibition effect on HBV expression was observed in the transfected 2.2.15 cells and transgenic mice.RESULTS: The Gal-PLL and asODNs could form stable complex at a molar ratio of 2:1. As shown in the HBV-transfected 2.2.15 cells, the inhibition effects of asODNs alone and asODNs conjugated to Gal-PLL, at 10μmol/L for both, on HBsAg and HBeAg production were different,the former being 70 % and 58 %, respectively, and the latter being 96 % and 82 %, respectively. A more pronounced reduction was also observed in viral DNA load in the culture supernatant for the test with Gal-PLL-asODNs. Among many mouse organs, livers retained more asODNs molecules after administration. The preferential concentration in liver was found to be 52.14 % for Gal-PLL-asODNs, as high as 2.38-fold of that for asODNs (21.9 %). Both elements decreased gradually in liver, with 2.9 % of the former, 5.99 % of the latter retained 24 hours after the administration. The injection interval, therefore, was recommended to be 24 hours. In the transgenic mice, serum HBsAg decreased significantly (P<0.01) at the 12th day after administrating Gal-PLL- asODNs, the serum HBV DNA turned negative in 4 of the 6 mice.CONCLUSION: Antisense oligodeoxynucleotides conjugated to Gal-PLL can be concentrated in liver and intaked by hepatocytic cells. This may result in specific inhibition of expression and replication of HBV in vitro and in vivo.
AIM:To describe distribution of the phosphorothioated antisense oligodeoxynucleotides (PS-asODNs) conjugated to galactosylated poly-L-lysine (GaI-PLL) in mice,and to observe their effects on expression of HBV gene in the 2.2. 15 cells and transgenic mice. METHODS:According to the result of direct sequencing of PCR amplified products,a 16 mer phosphorothioate analogue of the antisense oligodeoxynucleotides (PS- asODNs) directed against the HBV Us-like region was conjugated to the hepatotropic GaI-PLL molecules.Its distribution was demonstrated using asODNs labeled with ^(32)p at the 5' terminus with a T4-polynucleotide Kinase.Its inhibition effect on HBV expression was observed in the transfected 2.2.15 cells and transgenic mice. RESULTS:The GaI-PLL and asODNs could form stable complex at a molar ratio of 2:1.As shown in the HBV- transfected 2.2.15 cells,the inhibition effects of asODNs alone and asODNs conjugated to Gal-PLL,at 10 μmol/L for both,on HBsAg and HBeAg production were different,the former being 70 % and 58 %,respectively,and the latter being 96 % and 82 %,respectively.A more pronounced reduction was also observed in viral DNA load in the culture supernatant for the test with Gal-PLL-asODNs.Among many mouse organs,livers retained more asODNs molecules after administration.The preferential concentration in liver was found to be 52.14 % for GaI-PLL-asODNs,as high as 2.38- fold of that for asODNs (21.9%).Both elements decreased gradually in liver,with 2.9 % of the former,5.99 % of the latter retained 24 hours after the administration.The injection interval,therefore,was recommended to be 24 hours.In the transgenic mice,serum HBsAg decreased significantly (P<0.01) at the 12th day after administrating GaI-PLL- asODNs,the serum HBV DNA turned negative in 4 of the 6 mice. CONCLUSION:Antisense oligodeoxynucleotides conjugated to GaI-PLL can be concentrated in liver and intaked by hepatocytic cells.This may result in specific inhibition of expression and replication of HBV in vitro and in vivo.
基金
the Natural Science Foundation of China,No.39370648